Multi-omics profiling reveals key signaling pathways in ovarian cancer controlled by STAT3

Abstract

Our study presents a rich, multi-faceted summary of the molecular mechanisms impacted by <i>STAT3</i> deletion and provides new insight for <i>STAT3</i>'s potential as a therapeutic target in ovarian cancer.